These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 94455)

  • 1. OMGE--Study on prevalence of hepatitis B surface antigen in different liver diseases.
    Wewalka F; Hadziyannis S; Pesendorfer FX; Dragosics B; Base W
    Scand J Gastroenterol Suppl; 1979; 56():55-68. PubMed ID: 94455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-1-Foeto protein (AFP) and hepatitis B surface antigen (HBsAg) in various hepatic disorders.
    Gupta SC; Satsangi JK; Mehrotra TN; Sinha SN
    J Assoc Physicians India; 1979 Jan; 27(1):1-6. PubMed ID: 92470
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg).
    Omata M; Afroudakis A; Liew CT; Ashcavai M; Peters RL
    Gastroenterology; 1978 Dec; 75(6):1003-9. PubMed ID: 710851
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B virus infection and chronic liver disease in Taiwan.
    Chen DS; Sung JL
    Acta Hepatogastroenterol (Stuttg); 1978 Dec; 25(6):423-30. PubMed ID: 214987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen in various liver diseases in Iraq.
    Al-Balaghi SM; Kassir Z; Thewaini AJ
    J Trop Med Hyg; 1977 Dec; 80(12):248-51. PubMed ID: 606844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
    Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
    Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigen e and anti-e in primary liver cancer, cirrhosis, and viral hepatitis in Senegal].
    Sankale M; Sow AM; Thermos M
    Afr J Med Med Sci; 1977 Sep; 6(3):157-8. PubMed ID: 97943
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
    Ardito D; Bianco T; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of different subtypes of hepatitis B surface antigen in families of patients with chronic liver diseases.
    Sung JL; Chen DS
    Am J Gastroenterol; 1978 May; 69(5):559-64. PubMed ID: 210659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of hepatitis B antigens in hepatic tissue in various forms of acute hepatitis].
    Sarno EN; Vieira LM; Alvariz FG
    Arq Gastroenterol; 1984; 21(2):68-74. PubMed ID: 6393924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B surface antigen during the protracted course of viral hepatitis and chronic liver diseases].
    Belozerov ES; Sagandykov BB; Shabalin VV; Arkhipov GS
    Klin Med (Mosk); 1979 Jun; 57(6):80-4. PubMed ID: 459389
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of the presence of Australia antigen in liver diseases seen in a department of internal medicine in Abidjan].
    Soubeyrand J; Ticolat R; Leleu JP; Condat JM; Niamkey E; Diallo D; Manlan KL; Ouattara D; Beda BY
    Sem Hop; 1982 Dec; 58(46):2702-8. PubMed ID: 6297069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatitis B virus DNA sequences in liver in HBsAg seronegative patients with liver disease with and without anti-HBc antibodies.
    Fagan EA; Davison FD; Trowbridge R; Carman WF; Smith HM; Tedder R; Williams R
    Q J Med; 1991 Feb; 78(286):123-34. PubMed ID: 2031075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
    Picciotto L; Abrescia N; Ciampi R
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis B and primary cancer of the liver in intertropical Africa].
    Coursaget P; Yvonnet B; Barres JL; Perrin J; Tortey E; Diop B; Kocheleff P; Duflo B; M'Boup S; Diop-Mar I
    Rev Epidemiol Sante Publique; 1985; 33(4-5):267-75. PubMed ID: 2419946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies.
    Değertekin H; Yalçin K; Yakut M
    Turk J Gastroenterol; 2006 Mar; 17(1):25-34. PubMed ID: 16830274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.